TRPC3 and central nervous system cancer: In our present study, the results showed that the expression of TRPC1 and TRPC3 was significantly increased in glioma with IDH mutation status and 1p/19q codeletion status, while the expression of TRPC6, MCOLN1, MCOLN2, and MCOLN3 was significantly decreased.